This Week in JAMA | GenomeWeb

This Week in JAMA

Premium

In JAMA this week, researchers at the University of Texas MD Anderson Cancer Center and the University of Chicago report on the effects of brachytherapy versus whole-breast irradiation and subsequent mastectomy on the survival of older women with invasive breast cancer. The team retrospectively studied 92,735 women aged 67 and older with invasive breast cancer, 6,952 of whom were treated with brachytherapy after lumpectomy and 85 of whom were treated with whole-breast irradiation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.